These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. O'Neil WM; MacArthur RD; Farrough MJ; Doll MA; Fretland AJ; Hein DW; Crane LR; Svensson CK J Clin Pharmacol; 2002 Jun; 42(6):613-9. PubMed ID: 12043950 [TBL] [Abstract][Full Text] [Related]
4. Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals. Neuman MG; Malkiewicz IM; Phillips EJ; Rachlis AR; Ong D; Yeung E; Shear NH Ther Drug Monit; 2002 Dec; 24(6):728-36. PubMed ID: 12451289 [TBL] [Abstract][Full Text] [Related]
5. Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. Shapiro LE; Knowles SR; Weber E; Neuman MG; Shear NH Drug Saf; 2003; 26(3):187-95. PubMed ID: 12580647 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection. Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715 [TBL] [Abstract][Full Text] [Related]
7. Restarting trimethoprim-sulfamethoxazole after a hypersensitivity reaction in patients infected with the human immunodeficiency virus. Everson-Mays RE; Weidle PJ Am J Health Syst Pharm; 1997 Jul; 54(13):1545-50. PubMed ID: 9217946 [No Abstract] [Full Text] [Related]
8. The effect of cimetidine on the formation of sulfamethoxazole hydroxylamine in patients with human immunodeficiency virus. Lehmann DF; Newman N; Morse PD J Clin Pharmacol; 1998 May; 38(5):463-6. PubMed ID: 9602961 [TBL] [Abstract][Full Text] [Related]
9. Acetylator phenotype prevalence in HIV-infected patients without previous trimethoprim-sulfamethoxazole hypersensitivity. Quirino T; Bonfanti P; Arcidiacono M; Pusterla L; Cagni A; Scaglione F; Milazzo F Biomed Pharmacother; 1999 Jun; 53(5-6):286-7. PubMed ID: 10424252 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis. Abouraya M; Sacco JC; Kahl BS; Trepanier LA Br J Clin Pharmacol; 2011 Apr; 71(4):566-74. PubMed ID: 21204907 [TBL] [Abstract][Full Text] [Related]
11. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus. Marsh BJ Clin Infect Dis; 1997 Sep; 25(3):754-6. PubMed ID: 9314486 [No Abstract] [Full Text] [Related]
12. Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesis. van der Ven AJ; Vree TB; Koopmans PP; van der Meer JW J Antimicrob Chemother; 1996 May; 37 Suppl B():55-60. PubMed ID: 8818829 [TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection. Rieder MJ; King SM; Read S Pediatr Infect Dis J; 1997 Nov; 16(11):1028-31. PubMed ID: 9384334 [TBL] [Abstract][Full Text] [Related]
14. Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge? Koopmans PP; Burger DM Pharm World Sci; 1998 Dec; 20(6):253-7. PubMed ID: 9972526 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study. Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433 [TBL] [Abstract][Full Text] [Related]
16. Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients. Hemstreet BA; Page RL Pharmacotherapy; 2006 Apr; 26(4):551-7. PubMed ID: 16553515 [TBL] [Abstract][Full Text] [Related]
17. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection. Trepanier LA; Yoder AR; Bajad S; Beckwith MD; Bellehumeur JL; Graziano FM J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1041-50. PubMed ID: 15247557 [TBL] [Abstract][Full Text] [Related]
18. Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection. Rose EW; McCloskey WW Ann Pharmacother; 1998 Mar; 32(3):381-3. PubMed ID: 9533069 [No Abstract] [Full Text] [Related]
19. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis. Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796 [TBL] [Abstract][Full Text] [Related]
20. The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus. Lehmann DF; Liu A; Newman N; Blair DC J Clin Pharmacol; 1999 May; 39(5):533-7. PubMed ID: 10234602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]